Actinium-225 PRRT is a targeted radiation treatment for selected patients with advanced neuroendocrine tumors, especially when disease progresses after Lutetium-177 PRRT. This article explains how Ac-225 PRRT works, how it compares with Lu-177, who may be suitable, the treatment process in Germany, treatment cycles, follow-up, side effects, considerations for international patients, and the main factors that influence treatment cost and planning.
Details →Stage 4 neuroendocrine tumors with liver metastases spread to the liver, creating significant challenges due to their complex and aggressive nature.
Details →Neuroendocrine Tumors (NETs) are rare cancers that develop from neuroendocrine cells, which are responsible for producing hormones that regulate body functions.
Details →Neuroendocrine tumors (NETs) are rare cancers that develop from neuroendocrine cells, which have traits of both nerve cells and hormone-producing cells.
Details →Neuroendocrine tumors (NETs) are a rare group of cancers that develop from hormone-producing cells. In advanced stages, these tumors often spread to the liver, leading to serious health complications
Details →